Deletion of platelet CLEC-2 decreases GPIbα-mediated integrin αIIbβ3 activation and decreases thrombosis in TTP.
Deletion of platelet CLEC-2 decreases GPIbα-mediated integrin αIIbβ3 activation and decreases thrombosis in TTP.
复制标题
DOI:
10.1182/blood.2021012896
复制
发表时间:
2022-04-21
期刊:
影响因子:
20.3
通讯作者:
Xia, Lijun
中科院分区:
文献类型:
--
作者:
Shao, Bojing;Hoover, Christopher;Shi, Huiping;Kondo, Yuji;Lee, Robert H.;Chen, Junmei;Shan, Xindi;Song, Jianhua;McDaniel, J. Michael;Zhou, Meixiang;McGee, Samuel;Vanhoorelbeke, Karen;Bergmeier, Wolfgang;Lopez, Jose A.;George, James N.;Xia, Lijun
Using a mouse model of thrombotic thrombocytopenic purpura (TTP), Shao and colleagues show that the deletion of platelet CLEC-2 decreases pulmonary arterial thrombosis and the severity of thrombocytopenia. They also show that an integrin αaIIbβ3 antagonist, eptifibatide, or aspirin reduces pulmonary arterial thrombosis in the TTP mice. These data indicate that platelet CLEC-2 regulates GPIbα-mediated activation of integrin αIIbβ3 in TTP and may be pharmacologically manipulated for therapeutic benefit. Platelet CLEC-2 regulates VWF and GPIbα-mediated integrin αIIbβ3 activation that contributes to thrombosis in a mouse model of TTP. Eptifibatide and aspirin decrease thrombosis in mice with TTP, documenting the clinical importance of integrin αIIbβ3 activation. Microvascular thrombosis in patients with thrombotic thrombocytopenic purpura (TTP) is initiated by GPIbα-mediated platelet binding to von Willebrand factor (VWF). Binding of VWF to GPIbα causes activation of the platelet surface integrin αIIbβ3. However, the mechanism of GPIbα-initiated activation of αIIbβ3 and its clinical importance for microvascular thrombosis remain elusive. Deletion of platelet C-type lectin-like receptor 2 (CLEC-2) did not prevent VWF binding to platelets but specifically inhibited platelet aggregation induced by VWF binding in mice. Deletion of platelet CLEC-2 also inhibited αIIbβ3 activation induced by the binding of VWF to GPIbα. Using a mouse model of TTP, which was created by infusion of anti-mouse ADAMTS13 monoclonal antibodies followed by infusion of VWF, we found that deletion of platelet CLEC-2 decreased pulmonary arterial thrombosis and the severity of thrombocytopenia. Importantly, prophylactic oral administration of aspirin, an inhibitor of platelet activation, and therapeutic treatment of the TTP mice with eptifibatide, an integrin αIIbβ3 antagonist, reduced pulmonary arterial thrombosis in the TTP mouse model. Our observations demonstrate that GPIbα-mediated activation of integrin αIIbβ3 plays an important role in the formation of thrombosis in TTP. These observations suggest that prevention of platelet activation with aspirin may reduce the risk for thrombosis in patients with TTP.
登录
查看更多内容
DOI:
10.1111/jth.12144
发表时间:
2013-04
期刊:
Journal of thrombosis and haemostasis : JTH
影响因子:
--
作者:
Li R;Emsley J
通讯作者:
Emsley J
影响因子:
6.7
作者:
Jamasbi, Janina;Ayabe, Keng;Siess, Wolfgang
通讯作者:
Siess, Wolfgang
影响因子:
20.3
作者:
Li, ZY;Zhang, GY;Du, XP
通讯作者:
Du, XP
影响因子:
20.3
作者:
Kanaji, T;Russell, S;Ware, J
通讯作者:
Ware, J
影响因子:
20.3
作者:
Gitz, Eelo;Pollitt, Alice Y.;Watson, Steve P.
通讯作者:
Watson, Steve P.